N-glycosylated antibody

Details for Australian Patent Application No. 2004321433 (hide)

International Classifications

Event Publications

1 February 2007 PCT application entered the National Phase

PCT publication WO2006/005367 Priority application(s): WO2006/005367

16 September 2010 Assignment before Grant

Igeneon Krebs-Immuntherapie Forschungs-und Entwicklungs-AG The application has been assigned to Meridian Biopharmaceuticals GmbH; Vela Pharmazeutische Entwicklung und Laboranalytik GmbH; greenovation Biotech GmbH 2005

21 July 2011 Application Accepted

Published as AU-B-2004321433

15 September 2011 Assignment before Grant

Greenovation Biotech GmbH; Vela Pharmazeutische Entwicklung und Laboranalytik GmbH; Meridian Biopharmaceuticals GmbH The application has been assigned to Greenovation Biotech GmbH; Meridian Biopharmaceuticals GmbH 2005

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.